NCT02683317View on ClinicalTrials.gov

Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 22, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Retinopathy of Prematurity
Interventions
DIETARY_SUPPLEMENT

docosahexaenoic acid

Docosahexaenoic acid is a dietary supplement derived from algae.

DIETARY_SUPPLEMENT

sunflower oil

Sunflower similar to the excipient used in experimental group

Trial Locations (1)

06720

Unit of Research in Nutrition, Pediatric Hospital, Instituto Mexicano del Seguro Social, Mexico City

All Listed Sponsors
lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT02683317 - Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity | Biotech Hunter | Biotech Hunter